Characterization of silodosin and naftopidil in the treatment of bladder dysfunction in the spontaneously hypertensive rat.
about
Lower urinary tract symptoms, benign prostatic hyperplasia/benign prostatic enlargement and erectile dysfunction: are these conditions related to vascular dysfunction?Prostatic ischemia induces ventral prostatic hyperplasia in the SHR; possible mechanism of development of BPH.Tadalafil, a phosphodiesterase type 5 inhibitor, improves bladder blood supply and restores the initial phase of lower urinary tract dysfunction in diabetic rats.Effect of Naftopidil on Bladder Microcirculation in a Rat Model of Bladder Outlet Obstruction.Effects of an alpha1A/D-adrenoceptor antagonist, naftopidil, and a phosphodiesterase type 5 inhibitor, tadalafil, on urinary bladder remodeling in rats with spinal cord injury.
P2860
Characterization of silodosin and naftopidil in the treatment of bladder dysfunction in the spontaneously hypertensive rat.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Characterization of silodosin ...... pontaneously hypertensive rat.
@en
Characterization of silodosin ...... pontaneously hypertensive rat.
@nl
type
label
Characterization of silodosin ...... pontaneously hypertensive rat.
@en
Characterization of silodosin ...... pontaneously hypertensive rat.
@nl
prefLabel
Characterization of silodosin ...... pontaneously hypertensive rat.
@en
Characterization of silodosin ...... pontaneously hypertensive rat.
@nl
P2093
P2860
P356
P1476
Characterization of silodosin ...... pontaneously hypertensive rat.
@en
P2093
Fotios Dimitriadis
Fumiya Ohmasa
Keisuke Satoh
Motoaki Saito
Panagiota Tsounapi
Ryo Oikawa
Shogo Shimizu
Yukako Kinoshita
P2860
P304
P356
10.1002/NAU.22297
P577
2012-08-20T00:00:00Z